VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 355 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2013. The put-call ratio across all filers is 0.61 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $3,492,000 | -51.9% | 34,363 | -15.6% | 1.70% | -50.9% |
| Q3 2015 | $7,262,000 | -14.7% | 40,713 | +6.3% | 3.46% | +7.9% |
| Q2 2015 | $8,509,000 | +15.0% | 38,303 | +2.8% | 3.21% | +19.3% |
| Q1 2015 | $7,399,000 | +36.2% | 37,253 | -1.9% | 2.69% | +26.2% |
| Q4 2014 | $5,432,000 | +11.1% | 37,963 | +1.9% | 2.13% | +13.3% |
| Q3 2014 | $4,888,000 | +7.2% | 37,260 | +3.0% | 1.88% | +13.0% |
| Q2 2014 | $4,561,000 | +3.9% | 36,170 | +8.7% | 1.66% | -2.9% |
| Q1 2014 | $4,389,000 | +12.5% | 33,290 | +0.2% | 1.71% | +8.5% |
| Q4 2013 | $3,900,000 | +12.1% | 33,220 | -0.4% | 1.58% | +4.4% |
| Q3 2013 | $3,478,000 | -99.9% | 33,340 | 0.0% | 1.51% | +17.4% |
| Q2 2013 | $2,869,907,000 | – | 33,340 | – | 1.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |